Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-25

Clinical Trial Update: Observational Program Neo-Penotran® Forte

View source ↗

Summary

The document updates on a completed observational program for Neo-Penotran Forte, sponsored by Bayer, evaluating its use for vaginal candidiasis, bacterial vagi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neo-Penotran Forte (metronidazole and miconazole)

Snippet

Sponsor: Bayer | Conditions: Vaginal Candidiasis, Bacterial Vaginosis | Status: COMPLETED